The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

ovarian, and liver cancer, "added Dr Sajjanshetty. “A liquid biopsy can also monitor cancer treatment beyond just detection. Doctors can monitor their response to therapy and identify whether ...

Related: Shannon Miller on Her Ovarian Cancer Diagnosis. The Early Ovarian Cancer Sign Most People Miss. According to experts ...

Anixa Biosciences receives approval of protocol amendment for ovarian cancer CAR-T clinical trial: San Jose, California Friday, February 21, 2025, 18:00 Hrs [IST] Anixa Bioscience ...

At just 31 years old, Cameron Gourley had just gotten married when she noticed a lump during her typical self-exam.

First, the guidelines recommend that patients with suspected stage III-IV epithelial ovarian cancer be evaluated by a gynecologic oncologist before starting therapy to determine if they are ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer today announced that it, along with its partner Moffitt ...

Previously, Anixa and Moffitt had secured a single patient IND approval for an additional dose for a patient whose biopsy showed ... advance the treatment of ovarian cancer with CAR-T therapy.

Amendment expands the potential benefits of CAR-T therapy allowing a second dose and includes more ovarian cancer histologies SAN JOSE, Calif., Feb. 18, 2025 /PRNewswire/ ...